Roche secures EU approval for wider use of lung cancer drug

04/29/2010 | Reuters

Roche Holding said European regulators approved Tarceva as a maintenance treatment for advanced nonsmall-cell lung cancer. The drug received FDA approval earlier this month for this indication. Roche also said its Type 2 diabetes treatment taspoglutide yielded positive results in a late-stage trial.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL